findmyKOL
Clinical trialNCT07764887Not, yet, recruitingInterventional

Impacted Tooth Management and Osteoradionecrosis Risk in NPC

SponsorFirst Affiliated Hospital of Guangxi Medical UniversityEnrollment536Nasopharyngeal Carcinoma (NPC)Osteoradionecrosis of the Jaw
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This multicenter, randomized controlled trial is designed to determine whether omitting prophylactic extraction of impacted teeth before radiotherapy leads to an unacceptably higher risk of jaw osteoradionecrosis (JORN) compared with conventional prophylactic extraction in patients with non-metastatic nasopharyngeal carcinoma (NPC). JORN is a condition in which jawbone tissue is damaged and fails to heal properly after radiotherapy. A total of 536 eligible participants with at least one impacted tooth will be randomly assigned to either omit prophylactic extraction of impacted teeth before radiotherapy or undergo conventional prophylactic extraction before radiotherapy. All participants will receive standard curative-intent intensity-modulated radiotherapy (IMRT), with chemotherapy administered when indicated according to the study protocol. Participants will be followed for up to 5 years. The primary outcome is the incidence of JORN within 2 years after completion of radiotherapy. Secondary outcomes include longer-term incidence of JORN, overall survival, locoregional relapse-free survival, distant metastasis-free survival, quality of life, and treatment-related toxicities.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Min Kang, MD

    First Affiliated Hospital of Guangxi Medical University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Affiliated Hospital of Youjiang Medical University for Nationalities

    Baise City, Guangxi, China

  • Beihai People'S Hospital

    Beihai, Guangxi, China

  • Guigang People'S Hospital

    Guigang, Guangxi, China

  • the Affiliated Hospital of Guilin Medical University

    Guilin, Guangxi, China

  • Liuzhou People'S Hospital

    Liuzhou, Guangxi, China

  • Liuzhou Workers' Hospital

    Liuzhou, Guangxi, China

  • the First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • the People'S Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • Wuming Hospital Affiliated To Guangxi Medical University

    Nanning, Guangxi, China

  • Wuzhou Red Cross Hospital

    Wuzhou, Guangxi, China

  • the First People'S Hospital of Yulin

    Yulin, Guangxi, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Aug 2026
Primary completion
30 Nov 2029
Completion
30 Nov 2032
Last update posted
14 Aug 2026
Registered enrollment
536
Registry id
NCT07764887

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.